ClinicalTrials.govpublic full text
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
hepatocellular carcinoma, cadonilimab, lenvatinib, hepatic arterial infusion chemotherapy (haic), unresectable hepatocellular carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 903344
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.